POSTER SESSION V
Wednesday, March 11, 2009 — 9:30 AM - 12:00 Noon
Convention Center Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
GYNECOLOGIC PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
128
Characterization of Bone Tissue in the Ovary
(985)
C Habib, QJ Cao, CN Otis, L Pantanowitz - Baystate Medical Center/Tufts University School of Medicine, Springfield, MA
The Ovarian Stroma and Endometrial Carcinoma Subtype
(1011)
E Kostopoulou, S Angelidou, E Tziastoudi, A Papathanasiou, Z Tatsiou, CP Crum, G Koukoulis - University of Thessaly Medical School, Larissa, Greece; Hippokrateion Hospital, Thessaloniki, Greece; Harvard Medical School Brigham and Women's Hospital, Boston, MA
Neuroendocrine Cells as a Component of Ovarian Brenner Tumors: The Source of Rare Ovarian Carcinoid Tumors Associated with These Neoplasms
(967)
ED Euscher, A Malpica - MD Anderson Cancer Center, Houston, TX
Endocervical-Like (Mullerian-Type) Mucinous Borderline Tumors of the Ovary; Are They Mucinous Tumors?
(993)
JE Hwang, J Choi, Y-A Paik, YH Lee, JY Shim, K-R Kim - University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea; Pochon Cha University, Seoul, Republic of Korea; University of Ulsan Graduate School, Seoul, Republic of Korea
Endosalpingiosis in Ovarian Serous Tumors of Low Malignant Potential
(955)
S Clement-Kruzel, A Malpica, B Djordjevic - University of Texas Houston Medical School and M.D. Anderson Cancer Center, Houston, TX
Cross-Sectional Study of Ovarian Tumors among Hispanic Women Living in the United States
(1052)
ER Parrilla Castellar, MJ Merino, TP Diaz-Montes - NIH, Bethesda, MD; Johns Hopkins Medical Institutions, Baltimore, MD
Reproducibility in Assessing Ovarian Carcinoma Cell Types - A Transcanadian Study
(1007)
M Kobel, J Arseneau, P Baker, CA Ewanowich, D Fontaine, R Parker, DG Huntsman, CB Gilks - University of British Columbia, Vancouver, BC, Canada; McGill University, Montreal, QC, Canada; University of Manitoba, Winnipeg, MB, Canada; University of Alberta, Edmonton, AB, Canada; Memorial University, St. John's, NL, Canada; University of Calgary, Calgary, AB, Canada
Significant Differences in Tumor Cell Type in Early Versus Advanced Stage Ovarian Carcinoma
(979)
CB Gilks, M Kobel, SE Kalloger, DG Huntsman, J Santos, N Le, K Swenerton - University of British Columbia and British Columbia Cancer Agency, Vancouver, BC, Canada
Ovarian Low Grade Serous Neoplasms: Evaluation of Sampling Recommendations Based on Tumors Expected To Have Invasion (Those with Peritoneal Invasive Low Grade Serous Carcinoma (Invasive Implants))
(1078)
JD Seidman, JA Kraus, AV Yemelyanova, R Vang, BM Ronnett, RJ Kurman - Washington Hospital Center, Washington, DC; Johns Hopkins Medical Institutions, Baltimore, MD
Correlation of Immunohistochemical Staining Patterns of p53 with Mutational Analysis in Ovarian Carcinomas
(1101)
A Yemelyanova, R Vang, IM Shih, RJ Kurman - Johns Hopkins Hospital, Baltimore, MD
A Panel of Immunohistochemical Markers To Distinguish Ovarian from Uterine Serous Papillary Carcinomas
(1104)
Y Zhang, MT Garcia, T Koru-Sengul, P Ganjei-Azar - University of Miami - Jackson Memorial Hospital, Miami, FL; University of Miami - Sylvester Comprehensive Cancer Center, Miami, FL
Differential MGMT Promoter Methylation Profiling between Low Grade and High Grade Papillary Serous Ovarian Carcinoma
(930)
FA Shahin, X Ji, P Hui, F Abudul-Karim, W Liu, B Yang - Cleveland Clinic, Cleveland, OH; Yale University, CT; Case Western Reserve University, Cleveland, OH
Simultaneous Expression of Epidermal Growth Factor Receptor and Cellular Apoptosis Susceptibility Protein in Serous Ovarian Carcinoma: Relation with High Grade in a Two-Tier Grading System and Outcome
(945)
H Brustmann - Landesklinikum Thermenregion, Moedling, Lower Austria, Austria
Downregulation of miRNAs in Pluripotent Cancer Stem Cells Is Mirrored in Advanced Ovarian Serous Carcinoma
(970)
RJ Flavin, M Gallagher, S Elbaruni, CC Heffron, S O'Toole, P Smyth, A Laios, S Aherne, C Martin, K Lao, O Sheils, JJ O'Leary - Trinity College Dublin, Dublin, Ireland; Applied Biosystems, Foster City, CA
Human Ovarian Surface Epithelial Cells Can Give Rise to Papillary Serous Carcinoma under the Influence of Specific Oncogenes and the Microenvironment
(1107)
J Zheng, I Mercado-Uribe, P Liu, DG Rosen, G Yang, A Malpica, H Naora, N Auersperg, GB Mills, RC Bast, J Liu - UT MD Anderson Cancer Center, Houston, TX; Shangdong Univ, Jinan, China; University of British Columbia, Vancouver, BC, Canada
Phosphorylated FKHR Is Associated with Serous Neoplasia of the Ovary but Not with Mucinous Tumors
(1077)
M Schumann, B Karberg, J Behm, O Buchweitz, A Staebler - University of Tuebingen, Tuebingen, Germany; University of Muenster, Muenster, Germany
Mucinous Adenocarcinoma Involving the Ovary: Comparing Evaluation of the Classification Algorithms Using Tumor Size and Laterality
(1001)
ES Jung, JH Bae, A Lee, YJ Choi, JS Park, KY Lee - Kangnam St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea
Scoring with MUC2, MUC5, CK7, CK20, CDX2, CEA Immnohistochemical Staining Results Can Be Useful in Identifying Metastatic Colorectal Carcinoma Involving Ovary from Primary Ovarian Mucinous Adenocarcinoma
(1081)
JH Shin, CK Jung, A Lee, ES Jung, YJ Choi, KY Lee - Kangnam St Mary's Hospital, The Catholic University of Korea, Seoul, Korea
Metastatic Endocervical Adenocarcinoma in the Ovary: The MD Anderson Experience
(933)
I Aguilera-Barrantes, ED Euscher, A Malpica - MD Anderson, Houston, TX
Guanylyl Cyclase C Is a Specific Marker for Differentiating Primary and Metastatic Ovarian Mucinous Neoplasms
(943)
A Bombonati, V Ciocca, JP Palazzo, S Schulz, SA Waldman - Thomas Jefferson University Hospital, Philadelphia, PA
Reproducibility of Histological Diagnosis of Ovarian Clear Cell Adenocarcinoma
(1005)
T Kiyokawa, T Moriya, H Ishikura (deceased), SG Silverberg - Jikei University School of Medicine, Tokyo, Japan; Kawasaki Medical University, Kurashiki, Japan; Chiba University School of Medicine, Chiba, Japan; University of Maryland School of Medicine, Baltimore, MD
ZNF217 Gene Amplification and PIK3CA Mutation Are Associated with Ovarian Clear Cell Carcinoma
(1015)
KT Kuo, TL Mao, N Jinawath, RJ Kurman, TL Wang, IM Shih - National Taiwan University Hospital, Taipei, Taiwan; Johns Hopkins Medical Institutions, Baltimore, MD
The Oncofetal Protein IMP3 Is Differentially Expressed in Clear Cell Carcinoma of Ovary
(1106)
F Zhao, W Zheng, PPC Ip, MSK Siu, KF Tam, ANY Cheung - University of Hong Kong, Hong Kong SAR, Hong Kong; University of Arizona Medical College, Tucson, AZ
Activated Status of mTOR-HIF-1 a -VEGF Pathway in Ovarian Clear Cell Adenocarcinoma
(1100)
M Yasuda, S Hori, M Miyazawa, H Kajiwara, N Ogane, M Shimizu - Saitama Medical University International Medical Center, Saitama, Japan; Tokai University School of Medicine, Kanagawa, Japan; Kanagawa Cancer Center, Kanagawa, Japan
Low Levels of DNA Damage Based on Phosphorylated CHK2 Immunoreactivity Support Ovarian Endometrioid and Clear Cell Carcinomas as Type I Tumors
(1014)
MP Kshirsagar, W Jiang, RJ Kurman, I Shih - Johns Hopkins Medical Institutions, Baltimore, MD
Coordinate Expression of MUC4 and Palladin in Ovarian Epithelial Neoplasia: Role in Disease Progression
(1059)
MP Ponnusamy, R Nelson, S Chakraborty, R Miller, SM Lele, SK Batra - University of Nebraska Medical Center, Omaha, NE
Increased Expression of Inflammatory Markers in Type I and Type II Ovarian Carcinomas
(936)
H Arabi, S Bandyopadhyay, H Guan, K Hayek, A Munkarah, R Ali-Fehmi - Wayne State University, Detroit, MI
Immunohistochemical Expression of Folate Receptor-alpha in Ovarian Epithelial Neoplasms Bears Clinical and Pathological Significance
(1080)
J Shia, P Low, J Qin, C Hedvat, L Murphy, D Klimstra, R Soslow - Memorial Sloan-Kettering Cancer Center, NY
ALDH1 Expression in Ovarian Cancers: Correlation with Histologic Type and Clinical Prognosis
(950)
B Chang, GZ Liu, DG Rosen, XM Wang, LC Xiao, JS Liu - The University of Texas M. D. Anderson Cancer Center, Houston, TX; Baylor College of Medicine, Houston, TX
Role of EZH2 in Ovarian Carcinogenesis
(939)
S Bandyopadhyay, A Sood, AR Munkarah, MH Arabi, H Guan, K Hayek, R Ali-Fehmi - WSU/KCI/DMC, Detroit, MI; MDACC, Houston, TX; Wayne State University/Henry Ford Hospital System, Detroit, MI
Immunohistochemical Expression of LYVE-1 Is a Prognostic Factor in Ovarian Carcinoma
(1034)
A Marino-Enriquez, M Mendiola, J Barriuso, A Redondo, G Hernandez-Cortes, E Perez-Fernandez, A Suarez, D Hardisson - Hosp Univ La Paz, Madrid, Spain
Personalized Treatment of Ovarian Cancer: The Role of the Pathologist
(1096)
DE Westfall, B Karlan, D Barbuto, EG Silva - Cedars-Sinai Medical Center, Los Angeles, CA
Primitive Neuroectodermal Tumors of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Study of 18 Cases
(1010)
S Kojiro, A Quer, M Snuderl, D Daya, T Hayashi, L Bosincu, F Ogawa, Q Vu, AE Rosenberg, AJ Iafrate, E Oliva - Massachusetts General Hospital, Boston, MA; McMaster Hospital, Hamilton, ON, Canada; Saitama International Medical Center, Hidaka, Saitama, Japan; Universita di Sassari, Sassari, Italy; Prefectural Miyazaki Hospital, Miyazaki, Japan
SALL4 Is a Novel Sensitive and Specific Marker for Ovarian Primitive Germ Cell Tumors and Distinguishes Yolk Sac Tumor from Clear Cell Carcinoma
(946)
D Cao, S Guo, RW Allan, AM West, K Molberg, Y Peng - Washington University in Saint Louis, Saint Louis, MO; Xijing Hospital, Xian, Shanxi, China; University of Florida, Gainesville, FL; UT-Southwestern Medical Center, Dallas, TX
Confirmation of the Germ Cell Origin of Ovarian Tumours Using a Standard Panel of Microsatellite Markers
(932)
A Adamiak, I Schrader, J Senz, CB Gilks, DG Huntsman - University of British Columbia, Vancouver, BC, Canada; BC Cancer Agency, Vancouver, BC, Canada
button next to any title to add to Itinerary Planner...
Add
